ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

clinical trial

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00026364

P6099clinical trial phasephase I clinical trialQ5452194
P17countryUnited States of AmericaQ30
P582end time2006-12-01
P921main subjectrectum adenocarcinomaQ18554959
P2899minimum age18
P1132number of participants22
P4844research interventioncalcium oxalateQ412399
leucovorin calciumQ27077063
fluorouracilQ238512
irinotecanQ412197
P6153research siteDana–Farber Cancer InstituteQ1159198
P580start time2001-11-01
P8363study typeinterventional studyQ78089383
P1476titleA Phase I Study Of ZD1839 (Iressa) In Combination With Irinotecan, Leucovorin, And 5-Fluorouracil In Previously Untreated, Stage IV Colorectal Cancer

Search more.